AKT1 and leukemia: Embelin decreased the constitutive phosphorylation/activation levels of PI3K/AKT in bladder cancer, pancreatic cancer, and leukemia [57,87,88], and inhibited cell growth by inducing apoptosis via the PI3K/AKT pathway.